Athira pharma reports second quarter 2023 financial results and pipeline and business updates

Completed end of phase 2 meeting and continu e d engagement with u.s. food and drug administration appointed andrew gengos as chief financial officer and chief business officer maintains strong balance sheet to support innovative clinical development pipeline in neurodegenerative diseases through key inflection points
ATHA Ratings Summary
ATHA Quant Ranking